American International Group’s Serina Therapeutics SER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-366
Closed -$12K 3177
2020
Q1
$12K Sell
366
-13
-3% -$611 ﹤0.01% 2992
2019
Q4
$24K Sell
379
-3
-0.8% -$162 ﹤0.01% 2998
2019
Q3
$26K Sell
382
-3
-0.8% -$285 ﹤0.01% 2995
2019
Q2
$50K Buy
385
+218
+131% +$29.5K ﹤0.01% 2944
2019
Q1
$24K Sell
167
-1
-0.6% -$146 ﹤0.01% 2983
2018
Q4
$18K Buy
+168
New +$21.4K ﹤0.01% 3032

Other funds holding SER

American International Group's SER Position: Q2 2020 in Review

American International Group sold out of Serina Therapeutics (SER) in Q2 2020, closing a stake of 366 shares — an estimated $12K sold.

American International Group first reported a position in SER in Q4 2018 and held it in 6 quarters. The position peaked at $50K in Q2 2019. 48 funds tracked by Wall St. Rank hold SER as of Q2 2020.

  • American International Group reported no remaining Serina Therapeutics position as of Q2 2020 after selling out during the quarter.
  • American International Group sold 366 Serina Therapeutics shares in Q2 2020, an estimated $12K.
  • American International Group first reported a position in Serina Therapeutics in Q4 2018 and held it in 6 quarters.
  • American International Group's Serina Therapeutics position peaked at $50K in Q2 2019.
  • 48 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2020.

Based on American International Group's 13F filing for Q2 2020, filed 12 Aug 2020.